Case File
efta-02710768DOJ Data Set 11OtherEFTA02710768
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02710768
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Hosain Rahman
Sent:
Sunday, August 30, 2015 5:38 PM
To:
Jeffrey Epstein
Subject:
Jawbone Opportunity
Attachments:
Jawbone Mort investment analysis 2015-08-28.pdf; Untitled attachment 00277.htm
Jeffrey,
Nice to speak with you briefly. As promised, here's an =pdate on the financing round and business:
Investment Opportunity =or Mort (see attached):
For a $1.25M =nvestment you will elevate all your previous common and preferred to =he most senior equity preference
(after convertible note) with a 1.5x =reference. You currently have $SM in Series 5 preferred =ith - $1B in preference
ahead of it and $SM in common. Closing is on Monday.
Financing Round:
Although our latest major investment round was later than =xpected, we're pleased to have BlackRock as a partner.
BlackRock =nvested $220M in a convertible note in April and then added an =dditional $50M to it paired with $40M in
Series 8 Preferred equity from =P Morgan and Sequoia. Now, BlackRock is obligated to invest an =dditional $50M if we
raise an additional $35M in Series 8 Preferred by =he end of August. We're offering it to Major Investors and it's
=tructured to be a great way for holders of prior preferred to increase =heir preference coverage and seniority. Every
investor we've =poken to has been pleasantly surprised by how advantageous the terms =re: investors essentially get to
increase their preference on 9x their =oney invested. More details on the transaction and potential for you =re attached.
I know Andrew Lindsay on my team has spoken to =ichard Kahn about it a couple times.
Team:
We recently hired two =xceptional business leaders to partner with me to run the =usiness. With the addition of Sameer
Samat and Jason Child we =ave one of the premier executive teams of any late-stage =tartup.
Sameer =amat joined in June as our President. He was previously a VP at =oogle leading their commerce business and a
key lieutenant to Sundar =ichai, the new Google CEO. He's responsible for our entire =roduct development organization
including R&D, software, hardware =nd design. In the two months he's been here we've already =nstilled important
discipline in our development process that will help =s better launch products on time and on cost.
We also hired a new =FO. Jason Child joined last month from Groupon where he took them =ublic as their CFO. Prior to
that he was CFO of Amazon's =nternational business. He's excited about helping us grow with =he exploding wearables
market while keeping gross margins and operating =osts in line.
Sales =nd Partnerships:
EFTA_R1_02123357
EFTA02710768
Confidentially, we're in =alks with several key partners to integrate our products into their =fferings. We're deep in talks
with Microsoft on combining UP into their =ffice productivity suite. It would be huge for corporate =ellness. We're
discussing powering watches with our sensors and =oftware. Fossil is driving these conversations and eager to =artner.
They sells over 30M watches annually under brands such as =ichael Kors and Tory Burch so we're seriously considering
it.
Our recent sales have =een a mixed bag. We have successfully narrowed our focus to =earables exclusively in 2014 but
total sales were below =xpectations. Last year nearly 80% of our revenues were from UP =ands and this year we expect
it to be over 95%. Total sales in Q4 =014 and H1 2015 were hampered though by delayed funding and product
=aunches. We didn't have the necessary marketing support when we =aunched the products and they suffered from
low awareness. Despite this =e forecast wearable sales to grow 43% from $201M in 2014 to $288M in =015. We should
be fully on track going into 2016 and expect to =row with the market and generate $651M in revenues.
Market:
The wearables market is =rowing incredibly fast. Consumers are excited about the space and =eeking new products.
While we've ceded some of the market to =itbit we're seeing that consumers are not brand loyal at this early stage.
Best Buy recently surveyed their customers and found that =alf of them are interested in wearables and 92% of them
are not loyal =o any brand. It's reminiscent of the early stages of the =martphone market when Symbian had 50% of the
share in 2009 and fell to =% in 2012.
Products:
We launched three great =ew bands this year: UP2, UP3 and UP4. UP3 is the market's only =and with bioimpedance
sensors to get accurate heart rate and UP4 has =11 UP3's features with American Express payment functionality. =P2 has
all the functionality of UP24 but at lower cost with better =esign. The products have remarkable technology but the
clasp and =he capacitive touch input mechanism disappointed some customers. =e've worked quickly to resolve those
issues and expect to continue to =elight customers. We also have some beautiful new jewelry-like =P2 and UP3 designs
coming out in a couple weeks. Channel partners =ave been raving about them and if you send me the best address to
reach =ou at I'll send you one.
Development:
Our =urrent products are exciting but the real magic is what we have on =eck. We have the industry's best intellectual
property and we're =ncorporating it into groundbreaking new products with features such as =food pressure, stress
detection and respiration. We have even =ore advanced sensors in development. With our sensor development =e're
at the forefront of the convergence of health and consumer and the =arket opportunity for that is massive.
Let me know if you would like to =iscuss any of this further.
All my best,
Hosain
2
EFTA_R1_021 23358
EFTA02710769
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Phone
2123357Phone
2710768Phone
2710769Wire Ref
referenceRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.